Table 1. Characteristics of the 21 studies included in the meta-analysis of HIV and/or AIDS and the risk of melanoma.
Study | Location | Study period | Cohort description | Cohort size | Cases | Male % | Cohort median age at recruitment | Age range | Effect estimates providedb | ||
Pre-HAART | Post-HAART | AIDS | |||||||||
Cohort studies | |||||||||||
Calabresi et al., 2013 [39] | Italy, 1 province | 1999–2009 | HIV or AIDS | 5,090 | 8 | 82 | 35 | 19–64 | SIR | ||
Vogel et al., 2011 [35] | Germany, Bonn | 1996–2009 | HIV or AIDS | 1,476 | 1 | 81 | NS | 16–85 | SIR | ||
Seaberg et al., 2010 [37] | United States, 4 metropolitan areas | 1984–2007 | HIV | 6,949 | 9 | 100 | 32.6 | <30–>50 | SIR | ||
Franceschi et al., 2010 [34] | Switzerland, 9 cancer registries | 1985–2007 | HIV or AIDS | 9,429 | 11 | 81 | 32 | >16 | SIR | SIR | |
Powles et al., 2009 [33] | England, 1 clinical centre | 1996–2007 | HIV | 11,112 | 5 | 90 | NS | NS | SIR | ||
Long et al., 2008 [2] | United States, 1 clinical centre | 1996–2005 | HIV | 2,566 | 4 | 68 | 38 | <30-> = 50 | SIR | ||
Patel et al., 2008 [30] | United States, 13 cancer registries | 1992–2003 | HIV | 54,780 | NS | 76 | NS | 13–84 | |||
Serraino et al., 2007 [29] | Italy, 19 clinical centres France, 1 region | 1988–2004 | HIV | 8074 | 2 | 81 | 31.3 | <35->50 | |||
Hessol et al., 2004 [25] | United States | 1994–1995 | HIV or AIDS | 1,554 | 2 | 0 | NS | <30-50+ | |||
Herida et al., 2003 [24] | France, 12 cancer | 1992–1999 | HIV | 77,025 | 19 | 84 | Pre-HAART | 15-69 | SIR | SIR | |
registries | 39 (male); 33 (female) | ||||||||||
Post-HAART | |||||||||||
42(male); 38 (female) | |||||||||||
Record linkage studies | |||||||||||
Silverberg et al., 2011 [38] | United States, 1 state | 1996–2008 | HIV or AIDS | 20,775 | 34 | 91 | 40.6 | NS | RR | ||
Simard et al., 2010 [36] | United States, 15 regions | 1980–2004 | AIDS | 263,254 | 96 | 80 | 36 | 15-> = 50 | SIR | SIR | |
Bedimo et al., 2009 [40] | United States | 1997–2004 | HIV or AIDS | 33,420 | 96 | 98 | NS | NS | IRR | ||
Dal Maso et al., 2009 [31] | Italy, 24 cancer registries | 1986–2005 | HIVa or AIDS | 21,951 | 6 | Pre-HAART 32 | 16–69 | SIR | SIR | ||
Post-HAART 38 | |||||||||||
Van Leeuwen et al., 2009 [32] | Australia, national | 1982–2004 | HIV or AIDS | 17,175 | 53 | 92 | NS | 16–80 | SIR | SIR | |
Hessol et al., 2007 [28] | United States, San Francisco | 1990–2000 | HIVa or AIDS | 14,210 | 36 | 96 | NS | 16–86 | |||
Engels et al., 2006 [27] | United States, 6 states and | 1980–2002 | AIDS | 375,933 | 45 | 89 | Pre-HAART 37.7 | >15 | SIR | SIR | SIR |
5 cities | Post-HAART 39.3 | ||||||||||
Newnham et al., 2005 [26] | England | 1985–2001 | HIV or AIDS | 33,190 HIV 12,126 AIDS | 2 | 79 HIV 88 AIDS | NS | 15–60 | SIR | ||
Frisch et al., 2001 [22] | United States, 11 regions | 1978–1996 | HIVa or AIDS | 302,834 | 145 | 37 (male) 35 (female) | 15–69 | SIR | SIR | ||
Gallagher et al., 2001 [23] | United States, New York State | 1981–1994 | HIVa or AIDS | 122,993 | 24 | 89 | NS | 15–69 | SIR | ||
Cooksley et al., 1999 [21] | United States, single county | 1985–1994 | HIV or AIDS | 14,986 | 6 | 85 | 35 | <1–91 | SIR |
aHIV described if cohort entry was AIDS defined but person-year calculations included pre AIDS onset.
Compared with the general population.